 Josiane Broussard
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 18 | 2026 | 895 | 3.380 |
Why?
| | Sleep Deprivation | 10 | 2024 | 207 | 3.200 |
Why?
| | Circadian Rhythm | 13 | 2025 | 514 | 2.890 |
Why?
| | Insulin Resistance | 17 | 2026 | 1253 | 2.720 |
Why?
| | Obesity | 14 | 2026 | 3149 | 1.750 |
Why?
| | Sleep Wake Disorders | 4 | 2025 | 315 | 1.400 |
Why?
| | Insulin | 17 | 2026 | 2526 | 1.160 |
Why?
| | Blood Specimen Collection | 1 | 2025 | 37 | 0.880 |
Why?
| | Shift Work Schedule | 1 | 2025 | 10 | 0.870 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 154 | 0.860 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1798 | 0.860 |
Why?
| | Work Schedule Tolerance | 1 | 2025 | 51 | 0.850 |
Why?
| | Football | 1 | 2025 | 90 | 0.810 |
Why?
| | Triglycerides | 1 | 2024 | 529 | 0.720 |
Why?
| | Wakefulness | 1 | 2023 | 171 | 0.710 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2025 | 303 | 0.710 |
Why?
| | Dogs | 10 | 2020 | 518 | 0.680 |
Why?
| | Athletes | 1 | 2025 | 431 | 0.680 |
Why?
| | Postpartum Period | 1 | 2024 | 379 | 0.670 |
Why?
| | Glucose Clamp Technique | 9 | 2026 | 199 | 0.660 |
Why?
| | Diet, High-Fat | 2 | 2020 | 267 | 0.660 |
Why?
| | Lipids | 2 | 2024 | 723 | 0.660 |
Why?
| | Metabolic Diseases | 1 | 2022 | 114 | 0.640 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.630 |
Why?
| | Adipocytes | 2 | 2012 | 223 | 0.610 |
Why?
| | Hyperinsulinism | 3 | 2016 | 115 | 0.550 |
Why?
| | Blood Pressure | 1 | 2025 | 1785 | 0.530 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 393 | 0.530 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2017 | 97 | 0.510 |
Why?
| | Energy Metabolism | 4 | 2025 | 936 | 0.490 |
Why?
| | Chronobiology Disorders | 1 | 2016 | 16 | 0.490 |
Why?
| | Cross-Over Studies | 4 | 2025 | 617 | 0.470 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2016 | 54 | 0.460 |
Why?
| | Ghrelin | 1 | 2015 | 42 | 0.450 |
Why?
| | Eating | 3 | 2022 | 387 | 0.440 |
Why?
| | Exercise | 3 | 2025 | 2219 | 0.400 |
Why?
| | Glucose Tolerance Test | 5 | 2021 | 361 | 0.390 |
Why?
| | Lipid Metabolism | 2 | 2021 | 538 | 0.370 |
Why?
| | Sphingolipids | 2 | 2024 | 83 | 0.360 |
Why?
| | Heart Diseases | 1 | 2015 | 341 | 0.360 |
Why?
| | Random Allocation | 3 | 2020 | 366 | 0.350 |
Why?
| | Body Weight | 5 | 2025 | 976 | 0.330 |
Why?
| | Male | 23 | 2026 | 73950 | 0.320 |
Why?
| | Humans | 31 | 2026 | 147293 | 0.320 |
Why?
| | Health Status Disparities | 2 | 2024 | 324 | 0.300 |
Why?
| | Polysomnography | 2 | 2025 | 240 | 0.290 |
Why?
| | Blood Glucose | 10 | 2026 | 2359 | 0.280 |
Why?
| | Appetite | 2 | 2022 | 80 | 0.280 |
Why?
| | Cardiovascular Diseases | 3 | 2025 | 2218 | 0.280 |
Why?
| | Adipose Tissue | 2 | 2024 | 646 | 0.270 |
Why?
| | Energy Intake | 3 | 2022 | 514 | 0.270 |
Why?
| | Dietary Fats | 3 | 2020 | 309 | 0.260 |
Why?
| | Young Adult | 7 | 2025 | 14437 | 0.250 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 1077 | 0.240 |
Why?
| | Feeding Behavior | 2 | 2025 | 693 | 0.240 |
Why?
| | Adult | 11 | 2026 | 41405 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 2627 | 0.240 |
Why?
| | Animals | 14 | 2024 | 38410 | 0.230 |
Why?
| | Body Mass Index | 2 | 2025 | 2470 | 0.230 |
Why?
| | Glucose Intolerance | 2 | 2020 | 142 | 0.230 |
Why?
| | Venoms | 2 | 2016 | 22 | 0.230 |
Why?
| | Postmenopause | 2 | 2024 | 394 | 0.220 |
Why?
| | Lipolysis | 1 | 2024 | 44 | 0.210 |
Why?
| | Overweight | 2 | 2026 | 617 | 0.190 |
Why?
| | Circadian Clocks | 1 | 2023 | 59 | 0.190 |
Why?
| | Female | 13 | 2026 | 80076 | 0.190 |
Why?
| | Portal Vein | 2 | 2014 | 124 | 0.190 |
Why?
| | Fasting | 2 | 2022 | 280 | 0.190 |
Why?
| | Universities | 1 | 2025 | 453 | 0.180 |
Why?
| | Leptin | 2 | 2015 | 249 | 0.170 |
Why?
| | Homeostasis | 2 | 2023 | 651 | 0.170 |
Why?
| | Subcellular Fractions | 1 | 2021 | 73 | 0.170 |
Why?
| | Citric Acid Cycle | 1 | 2021 | 58 | 0.170 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 773 | 0.160 |
Why?
| | Hypoglycemic Agents | 3 | 2016 | 1415 | 0.160 |
Why?
| | Mitochondria, Muscle | 1 | 2021 | 125 | 0.150 |
Why?
| | Peptides | 2 | 2016 | 1003 | 0.150 |
Why?
| | Meals | 1 | 2020 | 132 | 0.150 |
Why?
| | Biomedical Research | 1 | 2025 | 723 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 867 | 0.140 |
Why?
| | Prevalence | 1 | 2025 | 2889 | 0.130 |
Why?
| | Diet | 2 | 2015 | 1284 | 0.130 |
Why?
| | Denervation | 2 | 2014 | 27 | 0.130 |
Why?
| | Norepinephrine | 2 | 2015 | 201 | 0.130 |
Why?
| | Methyl Ethers | 1 | 2016 | 19 | 0.120 |
Why?
| | Isoflurane | 1 | 2016 | 41 | 0.120 |
Why?
| | Middle Aged | 6 | 2026 | 36821 | 0.120 |
Why?
| | Subcutaneous Fat | 1 | 2016 | 79 | 0.120 |
Why?
| | Hydrocortisone | 2 | 2015 | 300 | 0.110 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2015 | 24 | 0.110 |
Why?
| | Fish Oils | 1 | 2015 | 27 | 0.110 |
Why?
| | Time Factors | 5 | 2025 | 7173 | 0.110 |
Why?
| | Biomarkers | 3 | 2015 | 4351 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2021 | 799 | 0.110 |
Why?
| | Abdominal Fat | 1 | 2015 | 51 | 0.110 |
Why?
| | Dysbiosis | 1 | 2016 | 188 | 0.110 |
Why?
| | Colorado | 1 | 2025 | 4591 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2015 | 47 | 0.110 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 27 | 0.100 |
Why?
| | Pregnancy | 2 | 2024 | 7274 | 0.100 |
Why?
| | Healthy Volunteers | 1 | 2015 | 219 | 0.100 |
Why?
| | Risk Factors | 2 | 2025 | 11017 | 0.100 |
Why?
| | Intra-Abdominal Fat | 1 | 2014 | 101 | 0.100 |
Why?
| | Prediabetic State | 1 | 2016 | 251 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6164 | 0.090 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 394 | 0.090 |
Why?
| | Thinness | 1 | 2012 | 100 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 848 | 0.090 |
Why?
| | Adolescent | 5 | 2024 | 22825 | 0.080 |
Why?
| | Hyperglycemia | 1 | 2014 | 381 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 440 | 0.080 |
Why?
| | Hemodynamics | 1 | 2015 | 1127 | 0.080 |
Why?
| | Cohort Studies | 1 | 2021 | 6099 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2010 | 181 | 0.070 |
Why?
| | Body Composition | 3 | 2020 | 694 | 0.070 |
Why?
| | Hypoglycemia | 1 | 2014 | 489 | 0.070 |
Why?
| | Glucose | 3 | 2023 | 1051 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2954 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2030 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4604 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3980 | 0.060 |
Why?
| | Signal Transduction | 2 | 2024 | 5272 | 0.060 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2025 | 103 | 0.050 |
Why?
| | Glycerol | 1 | 2024 | 90 | 0.050 |
Why?
| | Isoproterenol | 1 | 2024 | 96 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 56 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Reaction Time | 1 | 2005 | 438 | 0.050 |
Why?
| | Memory | 1 | 2005 | 300 | 0.050 |
Why?
| | Liver | 3 | 2016 | 1916 | 0.050 |
Why?
| | Nutritional Status | 1 | 2025 | 353 | 0.050 |
Why?
| | Behavior Therapy | 1 | 2025 | 297 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2020 | 17 | 0.040 |
Why?
| | Publications | 1 | 2021 | 47 | 0.040 |
Why?
| | Health | 1 | 2021 | 82 | 0.040 |
Why?
| | Disease | 1 | 2021 | 96 | 0.040 |
Why?
| | Actigraphy | 1 | 2020 | 148 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1481 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 566 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1912 | 0.030 |
Why?
| | Data Collection | 1 | 2020 | 652 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 2016 | 14 | 0.030 |
Why?
| | Sleep Stages | 1 | 2016 | 77 | 0.030 |
Why?
| | Propofol | 1 | 2016 | 88 | 0.030 |
Why?
| | Glucagon | 1 | 2016 | 114 | 0.030 |
Why?
| | Sympathectomy, Chemical | 1 | 2014 | 5 | 0.030 |
Why?
| | Omentum | 1 | 2014 | 9 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 15 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2014 | 72 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2014 | 123 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 813 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 170 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 88 | 0.030 |
Why?
| | Catecholamines | 1 | 2014 | 88 | 0.020 |
Why?
| | Organ Size | 1 | 2014 | 465 | 0.020 |
Why?
| | Intestines | 1 | 2016 | 356 | 0.020 |
Why?
| | Epinephrine | 1 | 2014 | 160 | 0.020 |
Why?
| | Models, Animal | 1 | 2014 | 394 | 0.020 |
Why?
| | Infant | 1 | 2023 | 10194 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2014 | 853 | 0.020 |
Why?
| | United States | 1 | 2025 | 16313 | 0.020 |
Why?
| | Habituation, Psychophysiologic | 1 | 2005 | 57 | 0.010 |
Why?
| | Memory, Short-Term | 1 | 2005 | 271 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 8164 | 0.010 |
Why?
|
|
Broussard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|